As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Combined, these two products made up 45% of the top line in the third quarter, so it's a legitimate worry. Still, BMS has ...

Coverage options include selling price valuation for wine in production and finished products, as well as protection for ...

BMS Group (BMS), a re/insurance broker, has introduced BMS Bacchus, a specialised stock throughput insurance solution for ...

ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

The Chicago-based firm earlier announced that its two Phase II EMPOWER trials investigating emraclidine as a once-daily, oral ...

UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The ...

Power Queen, the leader in lithium battery technology, introduces its latest innovation: the 12V 280Ah Low Temperature Deep ...

In Germany, abberations were seen on 32 occasions. Cumulatively, a total of 89 products were scrutinised. The BMS products in question include NAN, Illuma, S-26, Belsol, Beba, Little Steps ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.